Joseph France
Stock Analyst at Cantor Fitzgerald
(2.65)
# 1,849
Out of 5,182 analysts
55
Total ratings
65.71%
Success rate
10.74%
Average return
Main Sectors:
Stocks Rated by Joseph France
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $83 → $85 | $27.00 | +214.81% | 7 | Sep 14, 2023 | |
| HCA HCA Healthcare | Maintains: Buy | $285 → $320 | $488.00 | -34.43% | 3 | Apr 24, 2023 | |
| ELV Elevance Health | Maintains: Buy | $565 → $550 | $323.05 | +70.25% | 1 | Apr 21, 2023 | |
| UNH UnitedHealth Group | Maintains: Buy | $590 → $600 | $324.63 | +84.83% | 4 | Apr 17, 2023 | |
| CCRN Cross Country Healthcare | Initiates: Buy | $30 | $9.86 | +204.26% | 9 | Mar 10, 2023 | |
| CVS CVS Health | Initiates: Buy | $120 | $77.30 | +55.24% | 2 | Jun 17, 2022 | |
| THC Tenet Healthcare | Initiates: Buy | $80 | $196.64 | -59.32% | 2 | Jun 17, 2022 | |
| UHS Universal Health Services | Initiates: Hold | $115 | $182.41 | -36.96% | 3 | Jun 17, 2022 | |
| CI The Cigna Group | Initiates: Hold | $270 | $278.64 | -3.10% | 2 | Jun 17, 2022 | |
| MOH Molina Healthcare | Initiates: Hold | $310 | $148.97 | +108.10% | 1 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5 | $3.16 | +58.23% | 2 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $510 | $205.14 | +148.61% | 3 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $38.17 | +161.99% | 2 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $50 | $200.11 | -75.01% | 3 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $103 → $107 | $76.57 | +39.74% | 3 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $10 | $2.20 | +354.55% | 2 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $94.32 | -18.36% | 1 | Sep 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $46 | $39.79 | +15.61% | 1 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $80 | $85.65 | -6.60% | 1 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $34 | $46.82 | -27.38% | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $21 | $17.37 | +20.90% | 1 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $7 | $20.12 | -65.21% | 1 | Jul 6, 2017 |
Acadia Healthcare Company
Sep 14, 2023
Maintains: Neutral
Price Target: $83 → $85
Current: $27.00
Upside: +214.81%
HCA Healthcare
Apr 24, 2023
Maintains: Buy
Price Target: $285 → $320
Current: $488.00
Upside: -34.43%
Elevance Health
Apr 21, 2023
Maintains: Buy
Price Target: $565 → $550
Current: $323.05
Upside: +70.25%
UnitedHealth Group
Apr 17, 2023
Maintains: Buy
Price Target: $590 → $600
Current: $324.63
Upside: +84.83%
Cross Country Healthcare
Mar 10, 2023
Initiates: Buy
Price Target: $30
Current: $9.86
Upside: +204.26%
CVS Health
Jun 17, 2022
Initiates: Buy
Price Target: $120
Current: $77.30
Upside: +55.24%
Tenet Healthcare
Jun 17, 2022
Initiates: Buy
Price Target: $80
Current: $196.64
Upside: -59.32%
Universal Health Services
Jun 17, 2022
Initiates: Hold
Price Target: $115
Current: $182.41
Upside: -36.96%
The Cigna Group
Jun 17, 2022
Initiates: Hold
Price Target: $270
Current: $278.64
Upside: -3.10%
Molina Healthcare
Jun 17, 2022
Initiates: Hold
Price Target: $310
Current: $148.97
Upside: +108.10%
Jun 17, 2022
Initiates: Hold
Price Target: $5
Current: $3.16
Upside: +58.23%
Jun 17, 2022
Initiates: Buy
Price Target: $510
Current: $205.14
Upside: +148.61%
Jun 17, 2022
Initiates: Buy
Price Target: $100
Current: $38.17
Upside: +161.99%
Nov 2, 2018
Maintains: Overweight
Price Target: $42 → $50
Current: $200.11
Upside: -75.01%
Nov 2, 2018
Maintains: Neutral
Price Target: $103 → $107
Current: $76.57
Upside: +39.74%
Sep 28, 2018
Downgrades: Neutral
Price Target: $12 → $10
Current: $2.20
Upside: +354.55%
Sep 13, 2018
Initiates: Overweight
Price Target: $77
Current: $94.32
Upside: -18.36%
Aug 10, 2018
Maintains: Overweight
Price Target: $45 → $46
Current: $39.79
Upside: +15.61%
Aug 8, 2018
Maintains: Neutral
Price Target: $75 → $80
Current: $85.65
Upside: -6.60%
Dec 21, 2017
Initiates: Overweight
Price Target: $34
Current: $46.82
Upside: -27.38%
Nov 7, 2017
Maintains: Overweight
Price Target: $20 → $21
Current: $17.37
Upside: +20.90%
Jul 6, 2017
Initiates: Overweight
Price Target: $7
Current: $20.12
Upside: -65.21%